In 2023, the hospital discharges for malignant neoplasm of the prostate in the UK were X units per hundred thousand persons. From 2024 to 2028, the forecasted data indicates a slight upward trend, with the value increasing from 78.0 to 78.6. The year-on-year variation suggests incremental growth: 0.13% from 2024 to 2025, and slightly higher rates in subsequent years, eventually reaching 0.26% from 2027 to 2028. The compounded annual growth rate (CAGR) over the five-year forecast period is estimated to be around 0.15%.

Future trends to watch for:

Potential breakthroughs in prostate cancer treatments impacting hospitalization rates.
Demographic shifts, such as an aging population, possibly increasing incidence rates.
Government health policies and early detection programs influencing discharge rates.